Current Status of Intravesical Therapies for Bladder Pain Syndrome (BPS): A Narrative Review of Emerging Evidence

A range of psychological factors, sleep problems, and pain intensities predicted both spread of pain, reduction of number of musculoskeletal pain sites, and the degree to which

Results from an in vitro bench study comparing the characteristics of two different sensor systems for bladder assessment are presented; a new cystometry system using a

Figure 2 Change in the pain treatment and control groups in the mood syndrome factor group (depression, anxiety, apathy, irritability, night-time behaviours and appetite and

Ketamine is the most studied NMDA receptor antagonist in clinical pain trials, and is commonly used for the treatment of refractory cancer pain, and as an opioid-sparing drug in

Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Botulinum toxin infiltrations versus local anaesthetic infiltrations in

We hypothesize that injections with BoNT-A in the calf muscles will reduce energy cost during walking, improve walking capacity, increase habitual physical activity, reduce pain

Are fibromyalgia patients a distinct patient group compared to patients suffering from chronic pain and chronic fatigue syndrome.. Does Slow Cortical Potentials

The current study provides empirical evidence that a nurse-based pain management programme (in-service education and rounding) significantly improved patient- reported pain